For an uninterrupted learning experience, please use Google Chrome, Safari or Firefox as your browser. If you use Internet Explorer, you may not be able to view or access parts of this course. *

305-22: Daily Synthesis

Discussion and highlight of content presented on June 11, 2022, at the APNA 20th Annual Clinical Psychopharmacology Institute, with emphasis on how to synthesize evidence-based information into practice.

Presenter:  Matthew Tierney, MS, APRN, FAAN

Disclosures: The APNA planners and faculty, with the exception of those listed below, have no relevant financial relationship with ineligible companies to disclose. All relevant financial relationships listed for these individuals have been mitigated. Off-label uses will not be discussed during this presentation.

CPI Planning Committee-Georgia L. Stevens, PhD, APRN, PMHCNS-BC is a consultant and on the speakers’ bureau for Otsuka-Lundbeck, Alkermes, and Janssen.

Julie A. Carbray, PhD, PMHNP-BC, PMHCNS-BC, APRN is on the advisory board for Alkermes and Supernus.

Session Length:  31 minutes

Target Audience:  RN, APRN

Learning Outcomes:
Upon completion of this presentation, the participant will be able to:

• Synthesize information learned at CPI conference and apply to clinical, teaching or administrative practice

Keywords:  Synthesis, PMH Nursing

Nursing Continuing Professional Development:
0.5 contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

The contact hours for this session expire:  July 31, 2024

*Internet Explorer is an outdated browser and therefore when using it, APNA eLearning Center courses often will not load or play properly. Because Internet Explorer is still the default browser on many devices, this is the number one issue that impacts learners’ ability to access their courses. For an uninterrupted learning experience, please download and use Google Chrome, Mozilla Firefox, Microsoft Edge, Safari, etc. If you continue to experience issues, you may need to update your browser.

For an uninterrupted learning experience, please use Google Chrome, Safari or Firefox as your browser. If you use Internet Explorer, you may not be able to view or access parts of this course. *

205-22: Daily Synthesis

Discussion and highlight of content presented on June 10, 2022, at the APNA 20th Annual Clinical Psychopharmacology Institute, with emphasis on how to synthesize evidence-based information into practice.

Presenter:  Matthew Tierney, MS, APRN, FAAN

Disclosures: The APNA planners and faculty, with the exception of those listed below, have no relevant financial relationship with ineligible companies to disclose. All relevant financial relationships listed for these individuals have been mitigated. Off-label uses will not be discussed during this presentation.

CPI Planning Committee-Georgia L. Stevens, PhD, APRN, PMHCNS-BC is a consultant and on the speakers’ bureau for Otsuka-Lundbeck, Alkermes, and Janssen.

Julie A. Carbray, PhD, PMHNP-BC, PMHCNS-BC, APRN is on the advisory board for Alkermes and Supernus.

Session Length:  23 minutes

Target Audience:  RN, APRN

Learning Outcomes:
Upon completion of this presentation, the participant will be able to:

• Synthesize information learned at CPI conference and apply to clinical, teaching or administrative practice.

Keywords:  Synthesis, PMH Nursing

Nursing Continuing Professional Development:
0.25 contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

The contact hours for this session expire:  July 31, 2024

*Internet Explorer is an outdated browser and therefore when using it, APNA eLearning Center courses often will not load or play properly. Because Internet Explorer is still the default browser on many devices, this is the number one issue that impacts learners’ ability to access their courses. For an uninterrupted learning experience, please download and use Google Chrome, Mozilla Firefox, Microsoft Edge, Safari, etc. If you continue to experience issues, you may need to update your browser.

For an uninterrupted learning experience, please use Google Chrome, Safari or Firefox as your browser. If you use Internet Explorer, you may not be able to view or access parts of this course.*

203-22: Clinical Management of Antisocial Personality Disorder

The presentation will focus on the clinical management of this vexing disorder, including pharmacotherapy strategies. The definition, epidemiology, and clinical features of antisocial personality disorder (ASPD) will be reviewed as well.

APNA supports the use of person-centered recovery language. Please be informed that non-recovery language is included in this presentation.

Presenter:  Donald W. Black, MD

Disclosures: The APNA planners and faculty, with the exception of those listed below, have no relevant financial relationship(s) with ineligible companies to disclose. All relevant financial relationships listed for these individuals have been mitigated. Off-label uses will be discussed during this presentation.

Dr. Donald W. Black, is a consultant for Boehringer Ingelheim and receives royalties from Merck.

CPI Planning Committee-Georgia L. Stevens, PhD, APRN, PMHCNS-BC, is a consultant and on the speakers’ bureau for Otsuka-Lundbeck, Alkermes, and Janssen.

Julie A. Carbray, PhD, PMHNP-BC, PMHCNS-BC, APRN, is on the advisory board for Alkermes and Supernus.

Session Length:  1 hour 24 minutes

Target Audience:  RN, APRN

Learning Outcome:
Upon completion of this presentation, the participant will be able to:

• Understand antisocial personality disorder and its clinical management.

Keywords:  Antisocial Personality Disorder, ASPD, Personality Disorders

Nursing Continuing Professional Development:
1.5 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

The contact hours for this session expire:  July 31, 2024

*Internet Explorer is an outdated browser and therefore when using it, APNA eLearning Center courses often will not load or play properly. Because Internet Explorer is still the default browser on many devices, this is the number one issue that impacts learners’ ability to access their courses. For an uninterrupted learning experience, please download and use Google Chrome, Mozilla Firefox, Microsoft Edge, Safari, etc. If you continue to experience issues, you may need to update your browser.

For an uninterrupted learning experience, please use Google Chrome, Safari or Firefox as your browser. If you use Internet Explorer, you may not be able to view or access parts of this course.*

201-22: Current Concepts in Neuromodulation 

How does neuromodulation compare with medication for the treatment of depression? This presentation will discuss neuromodulation principles, mechanisms of action, and novel treatment strategies and provide a comprehensive exploration of the interface between neuromodulation and multimodal therapies. 

Presenter:  Eudora Jones, DNP, RN, PMHNP-BC

Disclosures: The APNA planners and faculty, with the exception of those listed below, have no relevant financial relationship with ineligible companies to disclose. All relevant financial relationships listed for these individuals have been mitigated. Off-label uses will be discussed during this presentation.

CPI Planning Committee-Georgia L. Stevens, PhD, APRN, PMHCNS-BC, is a consultant and on the speakers’ bureau for Otsuka-Lundbeck, Alkermes, and Janssen.                                             

Julie A. Carbray, PhD, PMHNP-BC, PMHCNS-BC, APRN, is on the advisory board for Alkermes and Supernus.

Session Length:  1 hour 15 minutes

Target Audience:  RN, APRN

Learning Outcome:
Upon completion of this presentation, the participant will be able to:

• Describe neuromodulation principles, mechanisms of action, and novel treatment strategies.

Keywords:  ECT, Neuromodulation, Electroconvulsive Therapy, TMS, Transcranial Magnetic Stimulation

Nursing Continuing Professional Development:
1.25 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

The contact hours for this session expire:  July 31, 2024

*Internet Explorer is an outdated browser and therefore when using it, APNA eLearning Center courses often will not load or play properly. Because Internet Explorer is still the default browser on many devices, this is the number one issue that impacts learners’ ability to access their courses. For an uninterrupted learning experience, please download and use Google Chrome, Mozilla Firefox, Microsoft Edge, Safari, etc. If you continue to experience issues, you may need to update your browser.

For an uninterrupted learning experience, please use Google Chrome, Safari or Firefox as your browser. If you use Internet Explorer, you may not be able to view or access parts of this course.*

401-22: Implementing Research Findings in Community Treatment Facilities

The RAISE-ETP randomized controlled trial showed that the NAVIGATE treatment model was superior to standard care for individuals with a first episode of psychosis.  After the completion of the study, NAVIGATE has been implemented in 22 states and also internationally.  The presentation will review the challenges in implementing NAVIGATE in community treatment settings. 

Presenter:  Delbert G. Robinson, M.D.

Disclosures: The APNA planners and faculty, with the exception of those listed below, have no relevant financial relationship(s) with ineligible companies to disclose. All relevant financial relationships listed for these individuals have been mitigated. Off-label uses will be discussed during this presentation.

Dr. Delbert Robinson, is a consultant for Teva Pharmaceuticals and is support for statistical analysis for Otsuka and Lundbeck.

CPI Planning Committee-Georgia L. Stevens, PhD, APRN, PMHCNS-BC, is a consultant and on the speakers’ bureau for Otsuka-Lundbeck, Alkermes, and Janssen. 

Julie A. Carbray, PhD, PMHNP-BC, PMHCNS-BC, APRN, is on the advisory board for Alkermes and Supernus.

Session Length:  1 hour 22 minutes

Target Audience:  APRN

Learning Outcome:
Upon completion of this presentation, the participant will be able to:

• Identify one challenge in implementing new evidence-based treatments into practice.

Keywords:  RAISE-ETP, NAVIGATE, Schizophrenia, Early Treatment Program, Community Treatment Facilities 

Nursing Continuing Professional Development:
1.5 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

The contact hours for this session expire:  July 31, 2024

*Internet Explorer is an outdated browser and therefore when using it, APNA eLearning Center courses often will not load or play properly. Because Internet Explorer is still the default browser on many devices, this is the number one issue that impacts learners’ ability to access their courses. For an uninterrupted learning experience, please download and use Google Chrome, Mozilla Firefox, Microsoft Edge, Safari, etc. If you continue to experience issues, you may need to update your browser.

For an uninterrupted learning experience, please use Google Chrome, Safari or Firefox as your browser. If you use Internet Explorer, you may not be able to view or access parts of this course.*

402-22: Treating Individuals with Eating Disorders: Insights & Challenges

Eating disorders have life-threatening consequences and require timely interventions. This presentation will discuss pharmacological and nonpharmacological evidence-based treatments for eating disorders.

Presenter:  Karen Jennings Mathis, PhD, APRN-CNP, PMHNP-BC

Disclosures: The APNA planners and faculty, with the exception of those listed below, have no relevant financial relationship with ineligible companies to disclose. All relevant financial relationships listed for these individuals have been mitigated. Off-label uses will be discussed during this presentation.

CPI Planning Committee-Georgia L. Stevens, PhD, APRN, PMHCNS-BC, is a consultant and on the speakers’ bureau for Otsuka-Lundbeck, Alkermes, and Janssen.

Julie A. Carbray, PhD, PMHNP-BC, PMHCNS-BC, APRN, is on the advisory board for Alkermes and Supernus.

Session Length:  1 hour 30 minutes

Target Audience:  RN, APRN

Learning Outcomes:
Upon completion of this presentation, the participant will be able to:

• Describe at least 2 medications used to treat eating disorders and the risks associated with psychopharmacological interventions.

Keywords:  Eating Disorders, Anorexia Nervosa, Bulimia Nervosa, Binge Eating

Nursing Continuing Professional Development:
1.5 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

The contact hours for this session expire:  July 31, 2024

*Internet Explorer is an outdated browser and therefore when using it, APNA eLearning Center courses often will not load or play properly. Because Internet Explorer is still the default browser on many devices, this is the number one issue that impacts learners’ ability to access their courses. For an uninterrupted learning experience, please download and use Google Chrome, Mozilla Firefox, Microsoft Edge, Safari, etc. If you continue to experience issues, you may need to update your browser.

For an uninterrupted learning experience, please use Google Chrome, Safari or Firefox as your browser. If you use Internet Explorer, you may not be able to view or access parts of this course. *

202-22: KEYNOTE: The Journey to Use Meds Optimally To Support Recovery

Using psychiatric meds is more than learning to take pills on schedule. It's a journey that has many challenges. In this keynote address, Patricia E. Deegan PhD will draw on her professional, and personal experience of recovery after a diagnosis of schizophrenia, to illustrate how nurses can play a key role in helping to assess and support people through the challenges of using psych meds.

Presenter:  Patricia E. Deegan, PhD

Disclosures: The APNA planners and faculty, with the exception of those listed below, have no relevant financial relationship with ineligible companies to disclose. All relevant financial relationships listed for these individuals have been mitigated. Off-label uses will not be discussed during this presentation.

CPI Planning Committee-Georgia L. Stevens, PhD, APRN, PMHCNS-BC, is a consultant and on the speakers’ bureau for Otsuka-Lundbeck, Alkermes, and Janssen.

Julie A. Carbray, PhD, PMHNP-BC, PMHCNS-BC, APRN, is on the advisory board for Alkermes and Supernus.

Session Length:  1 hour 28 minutes

Target Audience:  RN, APRN

Learning Outcomes:
Upon completion of this presentation, the participant will be able to:

• Identify 3 challenges a person may be experiencing on the journey to use medications optimally to support recovery.

Keywords:  Recovery, Medication Challenges, Medication Empowerment

Nursing Continuing Professional Development:
1.5 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

The contact hours for this session expire:  July 31, 2024

*Internet Explorer is an outdated browser and therefore when using it, APNA eLearning Center courses often will not load or play properly. Because Internet Explorer is still the default browser on many devices, this is the number one issue that impacts learners’ ability to access their courses. For an uninterrupted learning experience, please download and use Google Chrome, Mozilla Firefox, Microsoft Edge, Safari, etc. If you continue to experience issues, you may need to update your browser.

For an uninterrupted learning experience, please use Google Chrome, Safari or Firefox as your browser. If you use Internet Explorer, you may not be able to view or access parts of this course. *

302-22: KEYNOTE: Truths and Fallacies of Psychopharmacology

This lecture will describe aspects of the art and science of psychopharmacology, with special emphasis on correcting common misconceptions. It will be explained that medications can be used in one of two ways, either symptomatically or disease modifying. Almost all psychiatric medications are symptomatic and have no effect on the long-term diseases that underlie many psychiatric presentations. Implications of these observations for the use of psychiatric medications in clinical practice will be explored.  

Presenter:  Nassir Ghaemi, MD, MPH

Disclosures: The APNA planners and faculty, with the exception of those listed below, have no relevant financial relationship with ineligible companies to disclose. All relevant financial relationships listed for these individuals have been mitigated. Off-label uses will be discussed during this presentation.

CPI Planning Committee-Georgia L. Stevens, PhD, APRN, PMHCNS-BC, is a consultant and on the speakers’ bureau for Otsuka-Lundbeck, Alkermes, and Janssen.                                              

Julie A. Carbray, PhD, PMHNP-BC, PMHCNS-BC, APRN, is on the advisory board for Alkermes and Supernus.

Session Length:  1 hour 24 minutes

Target Audience:  APRN

Learning Outcomes:
Upon completion of this presentation, the participant will be able to:

• Analyze the distinction between symptomatic improvement and disease modification with psychiatric drugs and apply to research and practice.

Keywords:  Psychopharmacology, Psychiatric Medications, DSM

Nursing Continuing Professional Development:
1.5 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

The contact hours for this session expire:  July 31, 2024

*Internet Explorer is an outdated browser and therefore when using it, APNA eLearning Center courses often will not load or play properly. Because Internet Explorer is still the default browser on many devices, this is the number one issue that impacts learners’ ability to access their courses. For an uninterrupted learning experience, please download and use Google Chrome, Mozilla Firefox, Microsoft Edge, Safari, etc. If you continue to experience issues, you may need to update your browser.

For an uninterrupted learning experience, please use Google Chrome, Safari or Firefox as your browser. If you use Internet Explorer, you may not be able to view or access parts of this course.*

404-22: Women's Mental Health Care from Adolescence to Pregnancy and Beyond

Explore women's mental health across the lifespan from a pharmacological and psychotherapeutic woman-centered perspective, including up-to-date evidence about mental health disorders associated with the menstrual cycle, pregnancy, postpartum, and menopause. 

Presenter:  Tanya Tanner, PhD, MBA, APN, CNM, PMHNP-BC, FACNM; Stacie Olson DNP, APRN, PMHNP-BC

Disclosures: The APNA planners and faculty, with the exception of those listed below, have no relevant financial relationship with ineligible companies to disclose. All relevant financial relationships listed for these individuals have been mitigated. Off-label uses will be discussed during this presentation.

CPI Planning Committee-Georgia L. Stevens, PhD, APRN, PMHCNS-BC, is a consultant and on the speakers’ bureau for Otsuka-Lundbeck, Alkermes, and Janssen.

Julie A. Carbray, PhD, PMHNP-BC, PMHCNS-BC, APRN, is on the advisory board for Alkermes and Supernus.

Session Length:  1 hour 29 minutes

Target Audience:  RN, APRN

Learning Outcome:
Upon completion of this presentation, the participant will be able to:

• Discuss women's mental health across the lifespan from a pharmacological and psychotherapeutic woman-centered perspective.

Keywords:  Women's Mental Health, Pregnancy, Postpartum Depression, Premenstrual Syndrome

Nursing Continuing Professional Development:
1.5 Pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

The contact hours for this session expire:  July 31, 2024

*Internet Explorer is an outdated browser and therefore when using it, APNA eLearning Center courses often will not load or play properly. Because Internet Explorer is still the default browser on many devices, this is the number one issue that impacts learners’ ability to access their courses. For an uninterrupted learning experience, please download and use Google Chrome, Mozilla Firefox, Microsoft Edge, Safari, etc. If you continue to experience issues, you may need to update your browser.

For an uninterrupted learning experience, please use Google Chrome, Safari or Firefox as your browser. If you use Internet Explorer, you may not be able to view or access parts of this course.*

304-22: New insights into attention deficit hyperactivity disorder from neuroimaging and genomics

Understand new findings from large neuroimaging studies of brain structure and function in ADHD, as well how common and rarer genetic variations play a role in its genomics. Consider current barriers that must be overcome to apply this new information to clinical nursing practice.

Presenter:  Philip Shaw, B.M., B.Ch., Ph.D.

Disclosures: The APNA planners and faculty, with the exception of those listed below, have no relevant financial relationship with ineligible companies to disclose. All relevant financial relationships listed for these individuals have been mitigated. Off-label uses will not be discussed during this presentation.

CPI Planning Committee-Georgia L. Stevens, PhD, APRN, PMHCNS-BC, is a consultant and on the speakers’ bureau for Otsuka-Lundbeck, Alkermes, and Janssen.

Julie A. Carbray, PhD, PMHNP-BC, PMHCNS-BC, APRN, is on the advisory board for Alkermes and Supernus.

Session Length: 1 hour 13 minutes

Target Audience:  RN, APRN

Learning Outcome:
Upon completion of this presentation, the participant will be able to:

• Discuss recent advances in the genetics and brain imaging of attention deficit hyperactivity disorder.

Keywords:  ADHD, Attention Deficit Hyperactivity Disorder, Genomics, Neuroimaging

Nursing Continuing Professional Development:
1.25 contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

The contact hours for this session expire:  July 31, 2024

*Internet Explorer is an outdated browser and therefore when using it, APNA eLearning Center courses often will not load or play properly. Because Internet Explorer is still the default browser on many devices, this is the number one issue that impacts learners’ ability to access their courses. For an uninterrupted learning experience, please download and use Google Chrome, Mozilla Firefox, Microsoft Edge, Safari, etc. If you continue to experience issues, you may need to update your browser.